Eurofins Biomnis code

MIRTA

Synonyms

• Norset®

Specialty

Analytical Chemistry

Clinical significance

Specific noradrenergic and serotoninergic antidepressant. Central action presynaptic alpha-2 antagonist which increases central noradrenergic and serotoninergic neurotransmission. The sedative properties would appear to be due to the hitamine H1 receptor antagonist activity. Very low anticholinergic acitivity. Overdosage symptoms are limited to prolonged sedation.

Preanalytics

• 2 mL :
• Serum (do not use tubes with separator gel)
•   FROZEN
• Freezing within 4 hours

• A tube specifically for this analysis : Yes

Further information

Enclose the specific clinical information form (R13-INTGB : Medication quantification)
1 individual aliquot for this analysis.
Always draw blood at the same time before another administration
The following examinations can be performed on the same sample: Citalopram; Duloxetine; Fluoxetine; Fluvoxamaine; Mirtazapine; Paroxetine; Sertraline; Venlaflaxine.

Documents to download

• Specific clinical information form (R13-INTGB)

Methodology

Liquid chromatography / Tandem mass spectrometry (LC-TMS/MS)

Turnaround time

7 days